Skip to the main content.
Login Contact us

2 min read

Educating Patients to Help Eradicate Heart Disease and Stroke

Educating Patients to Help Eradicate Heart Disease and Stroke

February is about heart health awareness as we commemorate the 59th annual American Heart Month and February 3rd's National Wear Red Day. Informing your patients about the latest research and health tips will likely be top of mind, so we've compiled statistics and resources here, including information on Cardio AI—an imaging technology that assists cardiologists and radiologists in determining heart disease diagnosis.

February is your opportunity to combine efforts with the American Heart Association (AHA), the National Heart, Lung, and Blood Institute, the CDC's Division for Heart Disease and Stroke Prevention, and others in educating patients on how to reduce the risks of developing heart disease. 

Heart Health Statistics

Heart disease remains the leading cause of death in the United States, which is why ongoing education is imperative. Some current statistics to share with patients include: 

Additional statistical printouts can be found as well at:

Heart Month Resources 

Beyond encouraging patients to get regular checkups and screenings to detect potential issues, quick resources you can refer them to on the risks of heart disease and lifestyle changes to make, include: 

Additionally, the AHA's "Life's Essential 8" is a good breakdown with abundant resources that highlight the basics of maintaining healthy behaviors and health factors, including:

  • Not smoking

  • Getting physical activity

  • Maintaining a healthy diet

  • Maintaining healthy body weight

  • Good sleep health

  • Control of cholesterol

  • Healthy blood pressure

  • Balanced blood sugar 

Arterys Cardio AI Improves Diagnosis

As a provider of cardiac MRI software, we support American Heart Month and National Wear Red Day by highlighting the importance of advanced imaging technology in the early detection and management of heart disease. 

Heart_monthOur Cardio AI software helps cardiologists and radiologists to non-invasively and accurately diagnose and monitor heart conditions, allowing for prompt and effective treatment. Benefits of the technology include the ability to:

  • Reduce scan time by ≈ 30% 

  • Save up to 25 minutes per exam

  • Access to fast, repeatable, and editable results, as accurate as the experts

  • Easily edit contours and access results that automatically transfer to reports

  • View raw and index atrial volume values

  • Make more efficient and consistent diagnostic decisions


You can learn more about
Cardio AI by reading our data sheet.

Join us in the fight against heart disease by learning more about the benefits of Cardio AI.

Learn More About Cardio AI

Arterys And Therapixel Team Up For AI-powered Breast Cancer Solution

Arterys And Therapixel Team Up For AI-powered Breast Cancer Solution

Arterys, a Tempus company, has announced a US and EU distribution agreement with Therapixel, a medical imaging software company providing AI...

Read More
Arterys' Breast AI Suite: Transforming Breast Screening & Cancer Detection at SBI 2023

Arterys' Breast AI Suite: Transforming Breast Screening & Cancer Detection at SBI 2023

The 2023 Society of Breast Imaging (SBI) Breast Imaging Symposium is a must-attend event for radiologists and healthcare professionals involved in...

Read More
March Events: Procedural And Artificial Intelligence Developments In Oncology And Radiology

March Events: Procedural And Artificial Intelligence Developments In Oncology And Radiology

There are a lot of radiology conferences and events in March, and you can connect with the Arterys team at a number of them! Six specific events in...

Read More
Arterys has joined Tempus, and we are excited to reintroduce ourselves to you as Tempus Radiology.
Tempus is a leading technology company that is advancing precision medicine through the practical application of data and artificial intelligence in healthcare. By joining forces, Arterys’ product will be integrated into Tempus’ solutions, enabling providers to access a comprehensive patient view (now inclusive of radiology scans) and researchers to leverage this new data modality to optimize the drug development process.